Pathophysiology and treatment of resistant hypertension: the role of aldosterone and amiloride-sensitive sodium channels.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Seminars in Nephrology

• Publication date

  2014-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.semnephrol.2014.08.007PMID 25416662PMCID PMC4450367
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blood pressure and amiloride-sensitive sodium channels in vascular and renal cells

  2014cited by this paper
• The role of ENaC in vascular endothelium

  2014cited by this paper
• Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.

  2014cited by this paper
• 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

  2014cited by this paper
• Sodium surfeit and potassium deficit: keys to the pathogenesis of hypertension.

  2014cited by this paper
• The amiloride-sensitive endothelial sodium channel and vascular tone.

  2013cited by this paper
• Long‐term application of the aldosterone antagonist spironolactone prevents stiff endothelial cell syndrome

  2013cited by this paper
• Genetic disorders of potassium homeostasis.

  2013cited by this paper
• 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

  2013cited by this paper
• AT1 receptor blocker potentiates shear-stress induced nitric oxide production via modulation of eNOS phosphorylation of residues Thr(495) and Ser(1177.).

  2013cited by this paper
• Prevalence of apparent treatment-resistant hypertension among individuals with CKD.

  2013cited by this paper
• Vascular mineralocorticoid receptors regulate blood pressure effects on myogenic tone and role in aging.

  2013cited by this paper
• Primary aldosteronism and low-renin hypertension: a continuum?

  2013cited by this paper
• The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial.

  2013cited by this paper
• Resistant hypertension—its identification and epidemiology

  2013cited by this paper
• Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trial

  2013cited by this paper
• Clinical Benefit of Eplerenone in Patients With Mild Symptoms of Systolic Heart Failure Already Receiving Optimal Best Practice Background Drug Therapy: Analysis of the EMPHASIS-HF Study

  2013cited by this paper
• Genetic dissection of sodium and potassium transport along the aldosterone‐sensitive distal nephron: Importance in the control of blood pressure and hypertension

  2013cited by this paper
• Resistant hypertension—its identification and epidemiology

  2013cited by this paper
• Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone.

  2013cited by this paper
• Epithelial Sodium Channel Stiffens the Vascular Endothelium In Vitro and in Liddle Mice

  2013cited by this paper
• Direct Regulation of Blood Pressure by Smooth Muscle Cell Mineralocorticoid Receptors

  2012cited by this paper
• Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008

  2012cited by this paper
• Spironolactone Prevents Chlorthalidone-Induced Sympathetic Activation and Insulin Resistance in Hypertensive Patients

  2012cited by this paper
• Mineralocorticoid receptors in vascular function and disease.

  2012cited by this paper
• Angiotensin II-aldosterone interaction in human coronary microarteries involves GPR30, EGFR, and endothelial NO synthase.

  2012cited by this paper
• Eplerenone in patients with systolic heart failure and mild symptoms.

  2011cited by this paper
• Management of hypertension: summary of NICE guidance

  2011cited by this paper
• Evolution of the epithelial sodium channel and the sodium pump as limiting factors of aldosterone action on sodium transport.

  2011cited by this paper
• Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells.

  2011cited by this paper
• Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008

  2011cited by this paper
• Trends in 24-h urinary sodium excretion in the United States, 1957-2003: a systematic review.

  2010cited by this paper
• The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure

  2010cited by this paper
• The epithelial sodium channel (ENaC): Mediator of the aldosterone response in the vascular endothelium?

  2010cited by this paper
• Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study.

  2009cited by this paper
• Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

  2009cited by this paper
• Endothelial Epithelial Sodium Channel Inhibition Activates Endothelial Nitric Oxide Synthase via Phosphoinositide 3-Kinase/Akt in Small-Diameter Mesenteric Arteries

  2009cited by this paper
• Mineralocorticoid receptor blockers and chronic kidney disease.

  2009cited by this paper
• Editorial comment: Montani versus Osborn exchange of views

  2009cited by this paper
• Current computational models do not reveal the importance of the nervous system in long‐term control of arterial pressure

  2009cited by this paper
• Functional ENaC Channels Expressed in Endothelial Cells: a New Candidate for Mediating Shear Force

  2009cited by this paper
• Effects of Dietary Sodium Reduction on Blood Pressure in Subjects With Resistant Hypertension: Results From a Randomized Trial

  2009cited by this paper
• Vasoconstrictor effect of aldosterone via angiotensin II type 1 (AT1) receptor: possible role of AT1 receptor dimerization.

  2008cited by this paper
• Aldosterone and amiloride alter ENaC abundance in vascular endothelium

  2008cited by this paper
• Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

  2008cited by this paper
• Cross-Talk Between Mineralocorticoid and Angiotensin II Signaling for Cardiac Remodeling

  2008cited by this paper
• Kidney in Hypertension: Guyton Redux

  2008cited by this paper
• Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

  2008cited by this paper
• Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Resistance Artery Stiffness in Hypertensive Patients

  2008cited by this paper
• Prognostic influence of office and ambulatory blood pressures in resistant hypertension.

  2008cited by this paper
• 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

  2007cited by this paper
• Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior.

  2007cited by this paper
• Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.

  2007cited by this paper
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cited by this paper
• Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension

  2007cited by this paper
• Comparative Antihypertensive Effects of Hydrochlorothiazide and Chlorthalidone on Ambulatory and Office Blood Pressure

  2006cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic : the Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial ( ALLHAT )

  2006cited by this paper
• Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system.

  2005cited by this paper
• Aldosterone makes human endothelium stiff and vulnerable.

  2005cited by this paper
• Angiotensin II and Aldosterone Regulate Gene Transcription Via Functional Mineralocortocoid Receptors in Human Coronary Artery Smooth Muscle Cells

  2005cited by this paper
• The kidney as a determinant of genetic hypertension: evidence from renal transplantation studies.

  2005cited by this paper
• Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension.

  2005cited by this paper
• Serum aldosterone and the incidence of hypertension in nonhypertensive persons.

  2004cited by this paper
• Low-renin status in therapy-resistant hypertension: a clue to efficient treatment

  2004cited by this paper
• Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability.

  2004cited by this paper
• Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

  2003cited by this paper
• Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction

  2003cited by this paper
• Efficacy of low-dose spironolactone in subjects with resistant hypertension.

  2003cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2002cited by this paper
• Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension

  2002cited by this paper
• ETA Receptor Antagonist Prevents Blood Pressure Elevation and Vascular Remodeling in Aldosterone-Infused Rats

  2001cited by this paper
• Human Hypertension Caused by Mutations in WNK Kinases

  2001cited by this paper
• Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.

  2001cited by this paper
• Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet

  2001cited by this paper
• Molecular Mechanisms of Human Hypertension

  2001cited by this paper
• History about the discovery of the renin-angiotensin system.

  2001cited by this paper
• Blood Pressure Responses to Small Doses of Amiloride and Spironolactone in Normotensive Subjects

  2001cited by this paper
• Aldosterone-related genetic effects in hypertension

  2000cited by this paper
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

  2000cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein.

  1998cited by this paper
• Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives.

  1998cited by this paper
• 1996 Homer Smith Award Lecture. Cum grano salis: the epithelial sodium channel and the control of blood pressure.

  1997cited by this paper
• Liddle's syndrome: heritable human hypertension caused by mutations in the Beta subunit of the epithelial sodium channel.

  1995cited by this paper
• Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel.

  1994cited by this paper
• Liddle's syndrome: heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel

  1994cited by this paper
• The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels: Results of the Trials of Hypertension Prevention, Phase I

  1992cited by this paper
• The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I.

  1992cited by this paper
• Potassium and blood pressure.

  1991cited by this paper
• Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group.

  1988cited by this paper
• Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group.

  1988cited by this paper
• Renal function curve in patients with secondary forms of hypertension.

  1987cited by this paper
• Renal function curve--a key to understanding the pathogenesis of hypertension.

  1987cited by this paper
• Serum aldosterone and protein-binding variables in Yanomama Indians: a no-salt culture as compared to partially acculturated Guaymi Indians.

  1985cited by this paper
• Remission of essential hypertension after renal transplantation.

  1983cited by this paper
• Remission of essential hypertension after renal transplantation.

  1983cited by this paper
• Pharmacokinetic studies with chlorthalidone (hygroton®) in man

  1977cited by this paper
• Interindividual differences in chlorthalidone concentration in plasma and red cells of man after single and multiple doses

  1976cited by this paper
• Blood Pressure, Sodium Intake, and Sodium Related Hormones in the Yanomamo Indians, a “No‐salt” Culture

  1975cited by this paper
• Physical bases of circulatory transport : regulation and exchange

  1967cited by this paper

• Comparative efficacy and safety of aldosterone synthase inhibitors in hypertension: a Bayesian network meta-analysis of randomised controlled rials

  2025cites this paper
• Emergence of aldosterone synthase inhibitors for treatment of difficult to treat hypertension.

  2025cites this paper
• Efficacy and Safety of Lorundrostat in Uncontrolled and/or Treatment Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2025cites this paper
• Emerging Pharmacological Approaches for the Treatment of Arterial Hypertension

  2025cites this paper
• A rezisztens hypertoniák modern kezelése

  2024cites this paper
• Investigation and management of resistant hypertension: British and Irish Hypertension Society position statement

  2024cites this paper
• Serum Soluble Urokinase Plasminogen Activator Receptor Levels in Resistant Hypertension

  2024cites this paper
• Literature-Based Discovery to Elucidate the Biological Links between Resistant Hypertension and COVID-19

  2023cites this paper
• Taming resistant hypertension: The promise of novel pharmacologic approaches and renal denervation

  2023cites this paper
• Influence and implications of the renin–angiotensin–aldosterone system in obstructive sleep apnea: An updated systematic review and meta‐analysis

  2022cites this paper
• Diretrizes Brasileiras de Hipertensão Arterial – 2020

  2020cites this paper
• Sequential nephron blockade with combined diuretics improves diastolic function in patients with resistant hypertension

  2020cites this paper
• Posicionamento Brasileiro sobre Hipertensão Arterial Resistente – 2020

  2020cites this paper
• Brazilian Position Statement on Resistant Hypertension – 2020

  2020cites this paper
• Decreased neurotensin levels as a biomarker in resistant hypertension

  2020cites this paper
• [Uncontrolled Arterial Hypertension: Kidney, Neurohormonal Imbalance, and Approaches to Antihypertensive Drug Therapy].

  2019cites this paper
• Controlled Versus Uncontrolled Resistant Hypertension: Are They in the Same Bag?

  2018cites this paper
• Inappropriate activity of local renin-angiotensin-aldosterone system during high salt intake: impact on the cardio-renal axis

  2018cites this paper
• Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment

  2018cites this paper
• Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?

  2017cites this paper
• Resistant Hypertension: Mechanisms and Treatment

  2017cites this paper
• Citric Acid Metabolism in Resistant Hypertension: Underlying Mechanisms and Metabolic Prediction of Treatment Response

  2017cites this paper